Foreword: Normal tissue biologic response modifiers

1 p n June 27, 2003, the Radiation Therapy Oncology Group RTOG, www.rtog.org) held a symposium, “Normal Tissue iologic Response Modifiers,” in conjunction with the TOG’s semi-annual meeting in Montreal, Canada. The symposium brought together a diverse group of linicians and basic scientists, leading experts in the field, o foster the development of innovative research in mulicenter cooperative group projects. The topics covered ere the following: progress in defining mechanisms and otential targets for prevention of normal tissue injury fter radiation therapy, applications of interleukin-1 and 6 to the predictive diagnostic testing of radiation pneu